agilon health Inc

2026-08-11 20:02; UTC

Agilon Health Inc. shares are trading lower amid significant declines in the Health Care Services sub-sector. No specific news was identified for this movement.

2026-08-10 19:16; UTC

Agilon Health Inc. is trading higher today, despite an earlier pullback. Broader market conditions include a decline in U.S. stock futures amid job report news.

2026-08-07 20:03; UTC

Agilon Health Inc reported Q2 revenue of $1.49 billion and raised full-year guidance, supporting shares higher since Thursday's close despite an earlier pullback.

2026-08-06 20:51; UTC

Agilon Health Inc. shares are higher in after-market trading, reaching a peak of 5.47% above Thursday's close, with no specific news identified.

2026-08-05 23:26; UTC

Agilon Health reported Q2 earnings of $1.04 per share, exceeding estimates. Shares are trading higher in after-market hours following strong revenue guidance.

2026-08-04 19:56; UTC

Agilon Health Inc shares are lower today, continuing a decline since Monday. The stock remains below its 20-day moving average amid broader market strength.

2026-07-29 19:02; UTC

Agilon Health Inc is lower during Wednesday's session, reversing from earlier gains. The stock has declined since Tuesday's close with no specific news identified.

2026-07-28 19:26; UTC

Agilon Health Inc. shares are lower amid scrutiny over unprofitability and weak customer trends, reflecting broader negative sentiment in the market.

2026-07-27 19:56; UTC

Shares of agilon health Inc. are lower today, extending a four-day trend of declines. Earlier in the session, the stock pulled back from a high.

2026-07-24 19:51; UTC

Agilon Health Inc. shares are lower today, reversing a trend of higher closes since Thursday. Broader market volatility and tariff uncertainty may be influencing conditions.

2026-07-23 20:03; UTC

Agilon Health shares are lower after Citi downgraded the stock to Sell, raising the price target to $105 amid ongoing valuation concerns.

2026-07-20 20:01; UTC

agilon health inc shares are lower as analysts cite weak customer growth and a consensus price target of $71.57, indicating significant downside potential.